Which protein is lipitor's main effector?

Which protein does Lipitor primarily target in the liver?

Lipitor blocks the enzyme HMG-CoA reductase. This enzyme is the rate-limiting step in cholesterol production, so inhibiting it lowers LDL cholesterol in the blood.

How does HMG-CoA reductase inhibition affect cholesterol levels?

When the enzyme is blocked, liver cells make less cholesterol. The liver then increases the number of LDL receptors on its surface, pulling more LDL particles out of circulation and reducing circulating cholesterol.

What happens when HMG-CoA reductase activity drops?

Cells sense low cholesterol and activate SREBP transcription factors. SREBP upregulates LDL-receptor genes and other enzymes in the cholesterol pathway, amplifying the drug’s effect on plasma LDL.

Why do patients sometimes respond differently to Lipitor?

Genetic variants in the HMGCR gene itself or in LDL-receptor regulators can change how strongly the enzyme is inhibited or how many receptors are produced, leading to variable LDL reductions between individuals.

Can other enzymes compensate when HMG-CoA reductase is blocked?

Alternative pathways for isoprenoid production exist but cannot fully replace the HMG-CoA reductase step in cholesterol synthesis, which is why Lipitor remains effective despite partial pathway redundancy.

When does the Lipitor patent expire and are generics available?

The key U.S. patent for atorvastatin expired in 2011. Multiple generic manufacturers now supply the drug, and prices have fallen substantially since patent expiry.

Which companies make generic versions of Lipitor?

Major generic producers include Teva, Mylan, and Dr. Reddy’s Laboratories, all of which filed abbreviated new drug applications once the original patents lapsed.

How does Lipitor compare with other statins?

Atorvastatin is more potent on a milligram basis than simvastatin or pravastatin and has a longer half-life, allowing once-daily dosing. It reduces LDL by roughly 40–60 % at standard doses, a range similar to rosuvastatin at lower milligram amounts.

What side effects are patients most concerned about?

The most commonly discussed adverse effects are muscle pain or weakness and, rarely, elevated liver enzymes. These effects are linked to reduced production of coenzyme Q10 and other isoprenoids downstream of HMG-CoA reductase.

Sources:
[1] https://www.drugpatentwatch.com
[2] https://www.ncbi.nlm.nih.gov/books/NBK430685/